pilotitis

Patients

Innovation is already improving care across the NHS, but we are not yet consistently delivering at scale for the benefit of patients

News

Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.